This bill reauthorizes and extends critical stem cell research and transplantation programs established under the Stem Cell Therapeutic and Research Act of 2005. It specifically ensures the continued operation of the C.W. Bill Young Cell Transplantation Program . The legislation appropriates $33,009,000 annually for the C.W. Bill Young Cell Transplantation Program for fiscal years 2027 through 2031. Additionally, it extends the authorization for the vital cord blood inventory program , pushing its expiration date from 2026 to 2031, thereby supporting ongoing access to cord blood units for patients.